Zurich Cantonal Bank
TCRT icon

Zurich Cantonal Bank’s Alaunos Therapeutics TCRT Stock Holding History

Zurich Cantonal Bank’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-221
Closed -$22K – 2929
2022
Q1 		$22K Hold
221
– – ﹤0.01% 2659
2021
Q4 		$36K Hold
221
– – ﹤0.01% 2803
2021
Q3 		$60K Hold
221
– – ﹤0.01% 2564
2021
Q2 		$87K Hold
221
– – ﹤0.01% 2277
2021
Q1 		$119K Buy
221
+79
+56% +$49.2K ﹤0.01% 2065
2020
Q4 		$54K Hold
142
– – ﹤0.01% 2418
2020
Q3 		$54K Hold
142
– – ﹤0.01% 2239
2020
Q2 		$70K Hold
142
– – ﹤0.01% 2102
2020
Q1 		$52K Buy
142
+88
+163% +$45.5K ﹤0.01% 1920
2019
Q4 		$38K Hold
54
– – ﹤0.01% 2289
2019
Q3 		$35K Hold
54
– – ﹤0.01% 2247
2019
Q2 		$47K Hold
54
– – ﹤0.01% 2102
2019
Q1 		$31K Hold
54
– – ﹤0.01% 2258
2018
Q4 		$15K Hold
54
– – ﹤0.01% 2507
2018
Q3 		$26K Hold
54
– – ﹤0.01% 2418
2018
Q2 		$25K Hold
54
– – ﹤0.01% 2381
2018
Q1 		$32K Sell
54
-216
-80% -$135K ﹤0.01% 2284
2017
Q4 		$168K Buy
270
+31
+13% +$22.3K ﹤0.01% 1287
2017
Q3 		$221K Buy
239
+216
+939% +$192K ﹤0.01% 991
2017
Q2 		$22K Sell
23
-270
-92% -$265K ﹤0.01% 2219
2017
Q1 		$278K Sell
293
-306
-51% -$285K ﹤0.01% 930
2016
Q4 		$481K Sell
599
-3,274
-85% -$2.95M 0.01% 870
2016
Q3 		$3.27M Buy
3,873
+19
+0.5% +$15.3K 0.03% 498
2016
Q2 		$3.17M Buy
3,854
+111
+3% +$121K 0.04% 426
2016
Q1 		$4.17M Sell
3,743
-283
-7% -$290K 0.05% 357
2015
Q4 		$5.02M Buy
4,026
+191
+5% +$316K 0.06% 299
2015
Q3 		$5.18M Buy
3,835
+3,621
+1,692% +$5.98M 0.07% 253
2015
Q2 		$384K Buy
214
+73
+52% +$113K 0.01% 882
2015
Q1 		$228K Buy
+141
New +$209K ﹤0.01% 914

Other funds holding TCRT

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Zurich Cantonal Bank's TCRT Position: Q2 2022 in Review

Zurich Cantonal Bank sold out of Alaunos Therapeutics (TCRT) in Q2 2022, closing a stake of 221 shares — an estimated $22K sold.

Zurich Cantonal Bank first reported a position in TCRT in Q1 2015 and held it in 29 quarters. The position peaked at $5.18M in Q3 2015. 124 funds tracked by Wall St. Rank hold TCRT as of Q2 2022.

  • Zurich Cantonal Bank reported no remaining Alaunos Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Zurich Cantonal Bank sold 221 Alaunos Therapeutics shares in Q2 2022, an estimated $22K.
  • Zurich Cantonal Bank first reported a position in Alaunos Therapeutics in Q1 2015 and held it in 29 quarters.
  • Zurich Cantonal Bank's Alaunos Therapeutics position peaked at $5.18M in Q3 2015.
  • 124 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q2 2022.

Based on Zurich Cantonal Bank's 13F filing for Q2 2022, filed 9 Aug 2022.